Cargando…
PSME2 identifies immune-hot tumors in breast cancer and associates with well therapeutic response to immunotherapy
Breast cancer (BrCa) is a heterogeneous disease, which leads to unsatisfactory prognosis in females worldwide. Previous studies have proved that tumor immune microenvironment (TIME) plays crucial roles in oncogenesis, progression, and therapeutic resistance in Breast cancer. However, biomarkers rela...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793949/ https://www.ncbi.nlm.nih.gov/pubmed/36583022 http://dx.doi.org/10.3389/fgene.2022.1071270 |